Back in May of this year, the FDA approved a new method of human papillomavirus (HPV) testing in a healthcare setting. Rather than a standard Pap smear performed with a speculum -- a test dreaded by ...

Be proactive about your health Health screenings — physical exams, tests and procedures used to detect disease early — are important. Screening tests are designed to detect hidden disease ...

Many women are likely familiar with the Pap smear, but some might not know about the HPV test (human papillomavirus test). Pap smears and HPV tests are the most common ways to detect cervical cancer, ...

With the prospect of vaccines eliminating most cases of cervical cancer, the status of the Pap smear is uncertain. Two gynecologists address the issue. Ever since women began getting Pap tests more ...

Regular cervical cancer screening using HPV testing and/or Pap tests can prevent up to 90% or more of cervical cancers by detecting and treating precancerous lesions early, making it one of the most ...

Days after a government advisory panel rolled back its recommendations on mammography screening for breast cancer, another influential group issued revised guidelines on the use of Pap smears to ...

A new study suggests that a single screening with a DNA test for HPV is more effective than all current methods of detecting cervical cancer. Some doctors say the easier test will replace Pap smears.

If you can’t remember when you had your last pap smear, there’s a chance you might be due for another. So how often should you get a pap smear, exactly? We asked Dr. Margo Harrison, MD, OBGYN and Head ...

During the routine procedure, cells from your cervix are gently scraped away and examined for abnormal growth. The procedure is done at your doctor’s office. It may be mildly uncomfortable, but ...

The term ASCUS indicates minor cellular change detected on Papanicolaou (Pap) test results. Since most abnormal changes that occur to the cervix are the result of human papillomavirus (HPV) infection, ...

The predictive value of HER2 and p53 on outcomes after paclitaxel chemotherapy for metastatic breast cancer: Results from CALGB 9342 * δ= 30% of Ps (performance of the standard control group). MPT= ...